Lacktman Quoted on Telemedicine Reach and Provider Buy-in
30 December 2015
Managed Healthcare Executive
Partner Nathaniel Lacktman was quoted in a Managed Healthcare Executive article, “Does Telemedicine Improve Quality, Reduce Costs?” on December 30, 2015. When asked about the potential reach of Telemedicine, Lacktman said that “…using telemedicine doesn’t necessarily mean an all or nothing approach … In chronic cases, in particular, occasional face-to-face visits supplemented with remote health monitoring work well.” In addition, he addressed the issue of telemedicine adoption by providers, noting that “State legislatures are passing laws forcing health plans to cover the services, because the benefit is evident, but managed care is dragging its feet … Health plans aren’t comfortable enough to project costs.”
People
Related News
10 October 2024
In the News
Christopher King Highlights M&A Due Diligence Considerations
Foley & Lardner LLP partner Christopher King's comments on M&A due diligence at the Association of Corporate Counsel's annual meeting were highlighted in the Legal Dive article, "Can this marriage work? Legal tips for corporate M&A."
09 October 2024
In the News
Jason Mehta Weighs in on SEC Settlements, Clinical Research Fraud
Foley & Lardner LLP partner Jason Mehta commented on a recent health care litigation settlement with the U.S. Securities and Exchange Commission in the Clinical Trials Arena article, “Cassava Sciences: Phase III trials storm ahead amid controversy.”
08 October 2024
In the News
John Strom Assesses BIOSECURE ACT – 'Going to be tough to navigate'
Foley & Lardner LLP special counsel John Strom shared insight on the potential impact of the BIOSECURE ACT in the BioSpaces article, "WuXi Biologics Faces Uncertain Future in the U.S. After BIOSECURE Blow."